We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$3.85B
AUM Growth
-$284M
Cap. Flow
-$132M
Cap. Flow %
-3.43%
Top 10 Hldgs %
21.54%
Holding
5,768
New
656
Increased
2,740
Reduced
1,651
Closed
687

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$147M
2
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$138M
3
MU icon
Micron Technology
MU
+$66.1M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$40.1M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$36.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$104M
2
AAPL icon
Apple
AAPL
+$92M
3
AMZN icon
Amazon
AMZN
+$76.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M
5
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$58.1M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Financials 7.64%
3 Healthcare 7.18%
4 Consumer Discretionary 6.43%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
3001
CeriBell Inc
CBLL
$671M
$37.2K ﹤0.01%
2,027
+395
+24% +$7.94K
DJT icon
3002
Trump Media & Technology Group
DJT
$2.73B
$37.1K ﹤0.01%
4,003
+3,352
+515% +$38.5K
RPC
3003
Ridgepost Capital
RPC
$949M
$37.1K ﹤0.01%
5,111
+3,493
+216% +$31.7K
ZVRA icon
3004
Zevra Therapeutics
ZVRA
$562M
$37K ﹤0.01%
3,971
+1,662
+72% +$15K
RNA
3005
Atrium Therapeutics
RNA
$194M
$36.9K ﹤0.01%
+2,760
New +$38.8K
CRD.A icon
3006
Crawford & Co Class A
CRD.A
$532M
$36.8K ﹤0.01%
3,694
+2,593
+236% +$27.2K
DMRA
3007
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
$36.7K ﹤0.01%
1,418
+1,242
+706% +$31.9K
AIOT
3008
PowerFleet Inc
AIOT
$526M
$36.7K ﹤0.01%
11,918
+4,795
+67% +$20.1K
USAU icon
3009
US Gold Corp
USAU
$214M
$36.7K ﹤0.01%
2,413
+1,067
+79% +$19.1K
CTRN icon
3010
Citi Trends
CTRN
$555M
$36.6K ﹤0.01%
846
+404
+91% +$18.4K
LCTX icon
3011
Lineage Cell Therapeutics
LCTX
$269M
$36.6K ﹤0.01%
23,187
+3,716
+19% +$6.27K
PROK icon
3012
ProKidney
PROK
$316M
$36.6K ﹤0.01%
20,439
+20,424
+136,160% +$43.3K
HAYW icon
3013
Hayward Holdings
HAYW
$3.21B
$36.6K ﹤0.01%
2,734
+946
+53% +$14.7K
CTGO icon
3014
Contango Silver & Gold Inc
CTGO
$516M
$36.6K ﹤0.01%
1,950
+1,224
+169% +$32.3K
BBBY
3015
Bed Bath & Beyond
BBBY
$481M
$36.5K ﹤0.01%
7,872
+5,744
+270% +$32.1K
BCBP icon
3016
BCB Bancorp
BCBP
$173M
$36.5K ﹤0.01%
4,063
+3,107
+325% +$25.4K
IMUX icon
3017
Immunic
IMUX
$190M
$36.5K ﹤0.01%
3,287
+2,903
+756% +$26K
NUTX
3018
Nutex Health
NUTX
$1.01B
$36.4K ﹤0.01%
383
+143
+60% +$17.5K
AVR
3019
Anteris Technologies
AVR
$763M
$36.4K ﹤0.01%
6,558
+4,098
+167% +$23.5K
MPT
3020
Medical Properties Trust
MPT
$2.77B
$36.4K ﹤0.01%
7,852
+709
+10% +$3.7K
LARK icon
3021
Landmark Bancorp
LARK
$191M
$36.2K ﹤0.01%
1,460
+1,084
+288% +$28.7K
SNFCA icon
3022
Security National Financial
SNFCA
$244M
$36.2K ﹤0.01%
4,009
+2,745
+217% +$23.5K
KOLD icon
3023
ProShares UltraShort Bloomberg Natural Gas
KOLD
$115M
$36.2K ﹤0.01%
+1,667
New +$41.2K
RHI icon
3024
Robert Half
RHI
$3.87B
$36.1K ﹤0.01%
1,421
+971
+216% +$25.7K
FCAP icon
3025
First Capital
FCAP
$212M
$36.1K ﹤0.01%
727
+536
+281% +$27.7K
119 120
121
122 123

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2026 Portfolio in Review

As of Q1 2026, Tower Research Capital (TRC) held 5,768 positions worth $3.85B, down 6.9% from $4.13B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC) withdrew a net $132M in Q1 2026, closing 687 positions and reducing 1,651 holdings. Its most notable exit was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $58.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core US Aggregate Bond ETF worth $39.7M.

  • Tower Research Capital (TRC)'s largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 400,371 shares worth $39.7M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2026, an estimated $147M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2026 reduction was NVIDIA, cutting an estimated $104M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q1 2026, selling an estimated $58.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.85B portfolio in Q1 2026.
  • Tower Research Capital (TRC) opened 656 new positions and closed 687 in Q1 2026.
  • Tower Research Capital (TRC)'s portfolio value fell 6.9% quarter-over-quarter to $3.85B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.